Growpacker Inc. Announces Partnership with InterContinental Beverage Capital
Momentum Public Relations
Press Release: November 30, 2018
Growpacker Inc. (“Growpacker” or the “Company”), a contract manufacturer of various THC and CBD infused edibles and beverages in the United States, is pleased to announce it has signed a partnership agreement with InterContinental Beverage Capital (“IBC”).
IBC is a New York-based advisory and merchant banking firm with representative offices in Atlanta, Boca Raton, Los Angeles, and Lugano, Switzerland. The firm’s founders and partners have held top executive positions with multiple beverage companies, including MillerCoors, Coca-Cola, Red Bull, Diageo, and Cadbury Schweppes. IBC has expanded its footprint and influence in the cannabis infused beverage sector over the last year with the spread of the medical and recreational cannabis sector in the U.S.
The term of the agreement will allow Growpacker to leverage IBC for key market development services for its clients entering the THC & CBD infused beverage sector. Services will include brand development, business strategy & planning, advertising, and merchandising. IBC will have the opportunity to leverage Growpacker for turnkey formulation, packaging, manufacturing, and distribution of THC & CBD infused beverages for their growing list of clients wishing to enter the California market.
Growpacker has been ramping up its strategic partnerships across America to build the most comprehensive, experienced, and collaborative team possible in all ancillary sides of the cannabis industry. The company believes that the beverage and edible categories are primed for explosive growth over the coming years, and intends to align itself with powerful visionaries and disruptors who share the same vision.
“We are thrilled to be working with such experienced industry experts. Our company’s alignment with other best of breed companies and individuals will assist in hyper accelerating our near and long term goals”, said Stephen Boyd, Founder & CEO of Growpacker.
About Growpacker
Growpacker Inc. is a Canadian based company, which through its American interest in GP Holdings LLC, is engaged in expanding the ancillary side of the California cannabis industry. The company offers local and international brands key services, such as formulation, manufacturing, co-packing, and distribution for THC & CBD infused products.
- Published in Business, growpacker, Marijuana, Medical Marijuana, News Home
CROP Farm Signs California Processing and Retail Distribution Deals
Momentum Public Relations
Press Release: November 29, 2018
CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today it has signed a toll processing agreement with a manufacturing company that will produce oils, crumbles and distillates for sale in to the California market.
The raw material will be finished cannabis from CROP’s Humboldt County farm where the cannabis is awaiting sale, being trimmed or drying. The farm is currently flowering 10,000 sqft of canopy for a late stage harvest and is working on the permitting for its 2019 expansion including a proposed 30,000 sq ft automated greenhouse facility.
In addition, a distribution agreement is now in place for the cannabis which will be sold under the company’s Hempire brand for estimated gross revenue of approximately $1,600 per pound of flower. The farm has allocated 750lbs of inventory to be sold under the Hempire brand.
The distributor has offices in Oakland and Orange County. Their distribution network consists of approximately 350 licensed cannabis stores across California.
CROP CEO, Michael Yorke, stated: “Progress is continuing on becoming fully vertically integrated with self-serving Emerald Heights retail application. Processing and distribution are key agreements in getting our product onto hundreds of potential retail shelves. CROP’s core goal is maximizing its return on investment from tenant 2018 production, while preparing and building relationships for an exciting 2019.”
About CROP
CROP is publicly listed on the CSE and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is focused on cannabis branding and real estate assets. The Company’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada Cannabis farm, 1,865 acres of CBD farms, extraction in Nevada and joint ventures on West Hollywood and San Bernardino dispensary apps with international focuses in Jamaica and Italy.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line, US and Italian distribution rights to over 55 cannabis topical products and a portfolio of 16 Cannabis brands. CROP’s infrastructure has over 150,000 sq ft of built canopy and over 2,900 acres of real estate.
Disclaimer for Forward-Looking Information
Certain statements in this press release are forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected returns from the California Project; the technological effects of California Project; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: +1(604)484-4206
- Published in CROP Infrastructure, Marijuana, Medical Marijuana, News Home
ICR Announces Presenting Companies for Its 21st Annual Conference
Momentum Public Relations
Press Release: November 28, 2018
NEW YORK–(BUSINESS WIRE)–ICR, a leading strategic communications and advisory firm serving roughly 600 private and public company clients, today announced its preliminary list of presenting companies for its 2019 conference at the Grand Lakes Resort in Orlando, Florida. Public company presentations will take place on Monday, January 14th and Tuesday, January 15th, and private company presentations on Wednesday, January 16th
The ICR Conference, renowned for its dynamic and unique format, includes company presentations, breakout sessions, expert commentary and a multitude of networking opportunities. Specifically, the annual event brings together management teams from 150+ public and private growth companies, institutional investors, sell-side research analysts, private equity professionals, sponsoring investment bankers and select members of the media to discuss industry trends and forward strategies at the most critical time of the year.
“As we approach our 21st consecutive year, we remain committed to a conference platform that offers a unique opportunity to connect with the financial community and other key stakeholders,” said Tom Ryan, Chief Executive Officer, ICR. “We are excited to announce our preliminary 2019 presenters, a diverse group of both private and public companies that will offer vital insights on consumer trends as the New Year begins.”
Below is a preliminary list of public companies set to present at the 2019 conference:
- Abercrombie & Fitch (ANF)
- AgroFresh Solutions, Inc. (AGFS)
- American Eagle Outfitters, Inc. (AEO)
- American Vanguard Corporation (AVD)
- AMMO, Inc. (POWW)
- Aphria Inc. (APH.TO & APHQF)
- Aritzia (ATZ)
- ascena retail group, inc. (ASNA)
- At Home Group Inc. (HOME)
- Avon Products, Inc. (AVP)
- B&G Foods, Inc. (BGS)**
- Barfresh Food Group, Inc. (BRFH)
- BJ’s Wholesale Club (BJ)
- Bluegreen Vacations (BXG)
- Boot Barn (BOOT)
- Build-A-Bear Workshop, Inc. (BBW)
- Capital Park Holdings (LOGG)
- Carrols Restaurant Group, Inc. (TAST)
- Centric Brands Inc. (CTRC)
- Chico’s FAS Inc. (CHS)
- Chipotle Mexican Grill, Inc. (CMG)
- Chuy’s Holdings, Inc. (CHUY)
- Citi Trends, Inc. (CTRN)
- Crocs, Inc. (CROX)
- Cronos Group Inc. (CRON)
- Darden Restaurants, Inc. (DRI)
- Dave & Buster’s Entertainment, Inc. (PLAY)
- Del Frisco’s Restaurant Group, Inc. (DFRG)
- Del Taco Restaurants, Inc. (TACO)
- Delta Apparel, Inc. (DLA)
- Delta Galil Industries, LTD. (DELT)
- Denny’s Corporation (DENN)
- Destination XL Group, Inc. (DXLG)
- Dogness International Corporation (DOGZ)
- Domino’s Pizza (DPZ)
- Ecoark Holdings, Inc. (OTCQX:ZEST)
- El Pollo Loco, Inc. (LOCO)
- FAT Brands Inc. (FAT)
- Five Below, Inc. (FIVE)
- Floor & Décor Holdings, Inc. (FND)
- Fox Factory Holding Corp. (FOXF)
- Freshpet, Inc. (FRPT)
- Genesco Inc. (GCO)
- Genuine Parts Company (GPC)
- G-III Apparel Group, Ltd. (GIII)
- Goosehead Insurance, Inc. (GSHD)
- Green Thumb Industries (GTI)
- Green Dot (GDOT)
- GUESS?, Inc. (GES)
- Habit Restaurants Inc. (HABT)
- Helen of Troy Limited (HELE)
- Hudson Ltd. (HUD)
- IPic Entertainment (IPIC)
- J. Jill, Inc. (JILL)
- Kona Grill (KONA)
- Kornit Digital (KRNT)
- Landec Corporation (LNDC)
- Lands’ End (LE)
- Li & Fung (494 HK)
- Liberty Health Sciences (LHS)**
- LifeVantage Corporation (LFVN)
- Lifeway Foods, Inc. (LWAY)
- Limoneira Company (LMNR)
- lululemon athletica (LULU)
- MarineMax, Inc. (HZO)
- Medifast, Inc. (MED)
- MJardin Group (MJAR)
- Movado Group, Inc. (MOV)
- Noodles & Company (NDLS)
- Nu Skin Enterprises, Inc. (NUS)
- Ollie’s Bargain Outlet Holdings, Inc. (OLLI)
- Oxford (OXM)
- Party City Holdco Inc. (PRTY)
- Performance Food Group Company (PFGC)**
- PetIQ, Inc. (PETQ)
- Planet Fitness (PLNT)
- Prestige Consumer Healthcare Inc. (PBH)
- Primo Water Corporation (PRMW)
- Purple Innovation, Inc. (PRPL)
- Reed’s, Inc. (REED)
- RiceBran Technologies (RIBT)
- Rocky Brands, Inc. (RCKY)
- RTW Retailwinds, Inc. (RTW)
- Ruth’s Hospitality Group, Inc. (RUTH)
- ServiceMaster Global Holdings, Inc. (SERV)
- Shake Shack Inc. (SHAK)
- ShiftPixy, Inc. (PIXY)
- Shoe Carnival (SCVL)
- SpartanNash Company (SPTN)
- Sportsman’s Warehouse Holdings, Inc. (SPWH)
- SP Plus Corporation (SP)
- Stage Stores, Inc. (SSI)
- Stein Mart, Inc. (SMRT)
- Strauss Group (STRS IL)
- SunOpta Inc. (STKL)
- Sysco Corporation (SYY)
- Tailored Brands (TLRD)
- Texas Roadhouse, Inc. (TXRH)
- The Chefs’ Warehouse, Inc. (CHEF)
- The Children’s Place, Inc. (PLCE)
- The Lovesac Company (LOVE)
- The ONE Group Hospitality, Inc. (STKS)
- Tilly’s, Inc. (TLYS)
- Tilray, Inc. (TLRY)
- TILT (TILT)
- Titan Machinery Inc. (TITN)
- Tuesday Morning Corporation (TUES)
- Tupperware Brands Corporation (TUP)
- Urban Outfitters, Inc. (URBN)
- Vince Holding Corp. (VNCE)
- Waitr Holdings, Inc. (WTRH)
- Wingstop Inc. (WING)
- YETI (YETI)
- ZAGG Inc. (ZAGG)
- Zumiez, Inc. (ZUMZ)
**Attending Only
The following private companies are also set to present or attend at the upcoming conference with many more in attendance:
- AccelFoods
- ACE Cash Express
- AriZona Beverages
- Benihana Corporation
- Black Shamrock Partners
- Bluestone Lane
- BrightFarms
- Chicken Salad Chick
- City Winery
- CorePower Yoga
- Cryoshift Cryotherapy
- Dash Brands/Domino’s Pizza China
- DMA
- Dr. Martens
- eatsa
- Fat Tuesday
- Faherty Brand
- Farmwise LLC
- Fazoli’s
- Fogo de Chão
- FS Food Group
- Global Franchise Group
- Growpacker, Inc.
- Gusto
- hims
- Hydrofarm Holdings Group, Inc.
- iFLY Indoor Skydiving
- Jeni’s Splendid Ice Creams
- Joe & The Juice
- Lazy Dog Restaurant & Bar
- Mack Weldon
- Mavis Discount Tire
- MediaMath
- Meow Wolf
- Mile High Labs
- Mizzen+Main
- Nectar
- Oath Pizza
- OLAM Corp.
- Olo
- Paper Source
- Pari Passau
- Paytronix
- Pincho Factory
- Plate IQ
- Presto
- Punch Bowl Social
- Q Mixers
- r4 Technologies
- Ranir
- Restaurant Technologies
- Romano’s Macaroni Grill
- Scene75 Entertainment Centers
- Shoe Sensation, Inc.
- Souvla
- Spencer Spirit Holdings, Inc.
- STANCE
- Sterling Hospitality
- Terra’s Kitchen
- Thanx
- The Riddler
- thredUP
- Thunderbird Growth Corp.
- Tommy John
- Topgolf Entertainment Group
- Tophatter
- True Food Kitchen
- WellBiz Brands
- Wine.com
- Wolf & Shepherd, Inc.
- World of Beer Bar & Kitchen
- Xenial, Inc.
- Yumpingo
The event is by invitation only. To request an invitation, please visit http://www.icrconference.com or email info@icrconference.com. Follow the ICR Conference on Twitter at @ICRPR and join the conversation using the #ICRConference hashtag.
About The ICR Conference
The ICR Conference is a unique platform where public and private company management teams, institutional investors, sell-side research analysts, investment bankers, private equity professionals and select media connect and network with one another as the year begins. The event is one of the largest investment conferences of the year, featuring presentations by more than 150 public and private companies, with attendance regularly exceeding 2,300. For more information please visit http://www.icrconference.com.
About ICR
Established in 1998, ICR partners with companies to execute strategic communications and advisory programs that achieve business goals, build awareness and credibility, and enhance long-term enterprise value. The firm’s highly differentiated service model, which pairs capital markets veterans with senior communications professionals, brings deep sector knowledge and relationships to more than 500 clients in approximately 20 industries. Today, ICR is one of the largest and most experienced independent communications and advisory firms in North America maintaining offices in New York, Norwalk, Boston, San Francisco and Beijing. ICR also advises on capital markets transactions through its ICR Capital subsidiary. Learn more at www.icrinc.com. Follow us on Twitter at @ICRPR.
- Published in Business, growpacker, Marijuana, Medical Marijuana, News Home
Tetra Bio-Pharma Bolsters Intellectual Property Position and Product Pipeline
Momentum Public Relations
Press Release: November 27, 2018
Tetra Bio-Pharma Inc. (“Tetra” or “TBP”), (TSX VENTURE: TBP) (OTCQB: TBPMF), and Altus Formulation Inc. (“Altus”) today announced the signing of a non-binding term sheet (“Term Sheet“) to create a joint-venture to formulate, develop and deliver cannabinoid derived therapeutics for a number of indications. Altus has three distinct drug delivery technologies that will provide Tetra with significant strategic advantages over the competition. These include IntellitabTM abuse deterrent technology, FlexitabTM breakable sustained release tablet technology and SmartCelleTM nano-technology. SmartCelle’s ability to enhance the solubility of our THC and CBD products permits increased oral absorption and enables parenteral delivery. All platforms are protected by patents in force globally.
The Proposed Joint-Venture will provide Tetra Bio-Pharma with:
- Increased intellectual property protection for products developed under the joint venture;
- Access to abuse deterrent technology to minimize non-medical use of cannabinoids;
- An enhanced development pipeline addressing new therapeutic areas;
- Opportunities for disease-appropriate delivery including intranasal and intravenous delivery; and
- Increased oral drug absorption with immediate and extended release products.
Dr. Guy Chamberland, CEO and CSO of Tetra Bio-Pharma stated, “We are extremely excited about the creation of this joint venture as Altus brings many advantages to the table that will benefit our patients, their care providers and add tremendous value to the products being developed together. Their drug delivery technology will significantly strengthen our intellectual property portfolio.”
The White House Executive Office of the President of the United States along with several U.S. Federal agencies are encouraging pharmaceutical manufacturers to develop abuse-deterrent technologies. The Altus intellectual property will allow Tetra to bring formulations containing THC to market with a product label that clearly indicates its abuse-deterrence feature.
“This will be a major breakthrough for marketing THC drugs with opioid reduction claims at a time when society and the medical community are battling the epidemic abuse of opioids,” said Dr. Chamberland.
“We were highly impressed by Tetra’s science-driven approach to cannabinoid research and their proven ability to develop valuable medicines in this largely untapped new space,” said Dr. Damon Smith, CEO of Altus Formulation. “We greatly look forward to working with them and to bringing a range of life-changing new products to our patients.”
About Altus Formulation Inc.
Altus Formulation is a Quebec based drug formulation and development company using its proprietary and patent protected drug delivery technologies to generate novel, differentiated and cost effective new products for its partners and their patents. With a focus on safer to use formulations, Altus’ technologies also include SmartCelle technologies for intravenous or oral delivery of low solubility large and small molecules.
For more information, please visit www.altusformulation.com
About Tetra Bio-Pharma Inc.
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Health Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
For more information visit: www.tetrabiopharma.com
Source: Tetra Bio-Pharma
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Forward-looking statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research and development strategies, the success of this joint venture, the ability to obtain orphan drug status, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
For further information, please contact Altus Formulation Inc.
Damon Smith
CEO
514-883-3447
For further information, please contact Tetra Bio-Pharma Inc.
Robert Bechard
Executive Vice-President Corporate Development and Licensing
514-817-2514
Investors@tetrabiopharma.com
- Published in Medical Marijuana, News Home, Tetra Bio Pharma
Canada Cobalt Announces DTC Eligibility
Momentum Public Relations
Press Release: November 27, 2018
Canada Cobalt Works Inc. (TSXV: CCW) (OTCQB: CCWOF) (Frankfurt: 4T9B) (the “Company” or “Canada Cobalt”) is pleased to announce that it has secured DTC eligibility by the Depository Trust Company (“DTC”) for its shares traded on the OTC Market Group Inc.’s OTCQB Venture Market in the United States, under the symbol “CCWOF” effective November 26, 2018.
The DTC is a subsidiary of the Depository Trust & Clearing Corporation and manages the electronic clearing and settlement of publicly traded companies. Securities that are eligible to be electronically cleared and settled through DTC are considered “DTC eligible.” This electronic method of clearing securities speeds up the receipt of stock and cash, and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms by coming into compliance with their requirements. Being DTC eligible is expected to greatly simplify the process of trading and transferring the Company’s common shares on the OTCQB.
DTC is focused on creating liquidity and stability in the global capital markets by providing electronic clearance and settlement of equity trades. Having access to DTC services gives the Company greater exposure to the capital markets while at the same time offers various services including greater transparency of the Company’s shares.
About Canada Cobalt Works Inc. www.canadacobaltworks.com
Canada Cobalt is a pure play cobalt company focused on its past producing Castle mine in the Northern Ontario Cobalt Camp, Canada’s most prolific cobalt district. With underground access at Castle, a recently installed pilot plant to produce cobalt-rich gravity concentrates on site, and a proprietary hydrometallurgical process known as Re-2OX for the creation of technical grade cobalt sulphate as well as nickel-manganese-cobalt (NMC) formulations, Canada Cobalt is strategically positioned to become a vertically integrated North American leader in cobalt extraction and recovery.
“Frank J. Basa”
Frank J. Basa, P. Eng.
President and Chief Executive Officer
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. This news release may contain forward-looking statements including but not limited to comments regarding the timing and content of upcoming work programs, geological interpretations, receipt of property titles, potential mineral recovery processes, etc. Forward-looking statements address future events and conditions and therefore, involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated in such statements.
SOURCE Canada Cobalt Works Inc.
View original content: http://www.newswire.ca/en/releases/archive/November2018/27/c6983.html
- Published in Canada Cobalt Works, Mining, News Home
Crop’s ‘The Park’ Cannabis Farm Entering Sales Phase in ‘Major Step Forward’
Momentum Public Relations
Press Release: November 27, 2018
Crop Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today that its tenant at the greenhouse complex known as ‘The Park’, situated in Wheeler Park, Washington State, has submitted several strains of finished cannabis flower to quarantine as harvest continues.
Once the certificates of analysis are received the finished cannabis will be sold to licensed cannabis retailers. The company is currently accumulating inventories of the following strains:
9 LB HAMMER BANANA KUSH DARTH VADER DUTCH HAWAIIN GHOST TRAIN GORILLA GLUE JUGGERNAUT PITBULL SOUR DIESEL STAR KILLER THC BOMB WA WOO TIFFANY CBD
The Park’s 35,000 square foot cannabis greenhouse recently underwent a complete retrofit for hydroponic automation and the addition of 500 Gavita HPS grow lights. It has five flowering bays and is sited on nine acres with full scale production estimated at approximately 12,000 pounds of high-quality cannabis annually (about 1,000 pounds per month). The operating costs are about $50,000 (U.S.) per month.
CROP CEO, Michael Yorke, stated: “CROP has finished cannabis at two of its tenant farms and which have entered the sales cycle in Washington, which is a major step forward. I cannot over stress the importance of the purity of tenant products. By only using organic inputs on our farms, CROP is utterly dedicated to providing the cleanest and most natural cannabis for the end user, who, I am sure, will appreciate the quality and taste the difference of the products.”
Furthermore, the company is pleased to announce it has settled $883,500 in debt by the issuance of shares of the company at $0.30 per unit. Each unit has one common share and one commons share purchase warrant exercisable at $0.50 for a period of 18 months following the issuance date.
About CROP
Crop is publicly listed on the CSE and trades under the symbol “CROP” and in the US under the symbol “CRXPF”. CROP is focused on cannabis branding and real estate assets. The Company’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada Cannabis farm, 1,865 acres of CBD farms, extraction in Nevada and joint ventures on West Hollywood and San Bernardino dispensary apps with international focuses in Jamaica and Italy.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line, US and Italian distribution rights to over 55 cannabis topical products and a portfolio of 16 Cannabis brands. CROP’s infrastructure has over 150,000 sq ft of built canopy and over 2,900 acres of real estate.
Disclaimer for Forward-Looking Information
Certain statements in this press release are forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected returns from the Cannadrink Beverage; the technological effects of Cannadrink Beverage; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Phone: (604) 484-4206
Website: http://www.cropcorp.com
- Published in Business, CROP Infrastructure, Life Sciences, Marijuana, Medical Marijuana, News Home
MedX Signs MOU to Launch DermSecure™ in the Netherlands
Momentum Public Relations
Press Release: November 27, 2018
MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that it has signed a Memorandum of Understanding with a consortium of Dutch companies that will be launching an easy-access skin scanning/assessment program in the Netherlands, using MedX’s SIAscopy and DermSecureTM technologies. The consortium will integrate DermSecureTM with their existing platforms, which includes a suite of software applications used by a large majority of general practitioners in the Netherlands, and will build awareness campaigns through established healthcare initiatives and programs.
“The Dutch team is impressed with SIAscopy’s unique scanning technology, and the ability to seamlessly integrate our DermSecureTM platform into their suite of medical software applications that are used by more than 4,500 physicians in the Netherlands makes it a natural fit,” noted Scott Spearn, MedX’s President and CEO. “The broad reach of telemedicine from this many potential locations, with DermSecureTM providing the highest quality tools for the assessment by a team of trained Dermatologists, and the awareness built through their marketing relationships can enable the group to meet their objective of a truly national scanning/assessment program in the Netherlands, where there is a focus on cancer prevention and early screening.”
Pieter Severijns, Director of IvPG, one of the partners in this project and a company involved in programs and initiatives to improve healthcare in the Netherlands through the internet, noted “We have the ability through our programs to make people aware about the risks of melanoma, and allow those with higher risk or suspicious moles to easily access skin scanning and assessment by our top Dermatologists using DermSecureTM, through the large network of scanning centres that will be available to them.”
MedX will be working during the coming months to integrate its platform with those of its partners, while physicians are recruited to include DermSecureTM and MedX’s SIAscopy devices in their practices, and selected Dermatologists trained to provide timely assessment.
About MedX
MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin cancer with its DermSecure™ telemedicine platform, utilizing its SIAscopy technology. SIAscopy is also imbedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA (US), ARTG and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain. www.medxhealth.com.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This Media Release may contain forward-looking statements, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181127005308/en/
Contacts:
Scott Spearn, President and CEO
MedX Health Corp
905-670-4428 ext 229
Media Relations
Deborah Thompson
dthompson@medxhealth.com
416-918-9551
- Published in Business, Life Sciences, MedX Health Corp., News Home
Element 79 name change to Mondias Natural, rollback
Momentum Public Relations
Press Release: November 26, 2018
Also New Listing (C-NHP) Mondias Natural Products Inc
Pursuant to a special resolution passed by shareholders on Dec. 20, 2017, the company has consolidated its capital on a one-new-for-1.5-old basis. The name of the company has also been changed from Element 79 Capital Inc. to Mondias Natural Products Inc.
Effective at the opening of business on Wednesday, Nov. 28, 2018, the common shares of Mondias Natural Products will commence trading on the TSX Venture Exchange, and the common shares of Element 79 Capital will be delisted.
Postconsolidation and posttransactional capitalization: unlimited number of common shares with no par value, of which 63,135,805 common shares will be issued and outstanding
Escrow: 36,333,334 common shares, of which 3,633,333 common shares are released at the date of this bulletin
Transfer agent: Computershare Investor Services Inc., Montreal and Toronto
Trading symbol: NHP (new)
Cusip No.: 60922M100 (new)
- Published in Business, Life Sciences, Mondias Natural, News Home, Uncategorized
Growpacker Inc. Welcomes Blue Moon Founder Keith Villa as a Strategic Advisor
Momentum Public Relations
Press Release: November 26, 2018
Growpacker Inc. (“Growpacker” or the “Company”), a contract manufacturer of various THC and CBD infused edibles and beverages in the United States, is pleased to welcome Keith Villa as a strategic advisor to the company.
Keith created Blue Moon Brewing Company in 1995 as an operating unit of Coors Brewing Company, which later became MillerCoors. Keith is a third generation Coloradan with a Ph.D. in brewing science from the University of Brussels, a degree held by only a handful of people in the world.
Blue Moon’s Belgian White Ale, garnished by a Valencia orange slice, grew to become the #1 selling craft beer in the United States. During this time, Keith became a well-known brewmaster in the industry, appearing in Blue Moon advertisements, hosting beer events & dinners, serving as a celebrity & judge at beer competitions, and appearing in numerous brewing articles.
In early 2018, Keith retired from MillerCoors after 32 years and co-founded CERIA, Inc. (dba CERIA Brewing Company) with his wife, Jodi Villa. Their plan was to create an extraordinary cannabis infused de-alcoholized craft beer with THC that offered a similar onset time as alcohol. Fast-forward just 10-months later, and they have done exactly that with the Colorado launch in mid-December of CERIA’s Grainwave Belgian-Style White Ale with 5mg of THC, which will be followed by two additional styles and strengths in 2019 – an American Light Lager (2.5mg THC) and an IPA (10mg THC). These products will only be available to adult consumers 21 and up.
“We are very excited to have Keith join the team as a strategic advisor”, said Stephen Boyd, Chief Executive Officer of Growpacker. “The addition of Keith is instrumental to our company, as we believe that his experience will play a key role in developing the de-alcoholized THC-infused beverage segment, which is expected to become one of the fastest growing segments in the industry.”
Growpacker Inc., through its interest in GP Holdings, LLC, has been constructing its flagship cannabis manufacturing facility in Desert Hot Springs, California. The facility is expected to house a versatile array of processing and packaging lines that can address a multitude of product categories, including beverages (carbonated or noncarbonated teas, coffees, kombuchas, waters, beers, wines, spirits, etc), edibles (cookies, brownies, gummies, hard candies, caramels, lollipops, chocolate bars, enrobed chocolates, etc), flower products (weighted quarters, eighths, pre-rolls, etc), and other one-off type products.
The facility has been built from the ground up to adhere to FDA standards in the anticipation of a federal legalization in the near future, and is located in a city where manufacturing taxes on cannabis related products are currently zero percent, giving Growpacker a substantial competitive advantage in the manufacturing space. Growpacker expects the facility to be fully constructed by the end of Q4 2018, and expects to be in full production by the start of Q1 2019.
“We are developing one of the most versatile cannabis manufacturing facilities in California, a key infrastructure component that will accelerate the entire industry,” said Stephen Boyd. “We aim to become the go-to end-to-end cannabis manufacturing arm, which will enable companies to bring new products and brands to market exponentially faster, cheaper, and easier. The addition of Keith will bring a layer of experience that’s second to none in the industry, which will directly translate into the de-alcoholized THC-infused beverage products that we manufacture.”
About Growpacker
Growpacker Inc. is a Canadian based company, which through its American interest in GP Holdings LLC, is engaged in expanding the ancillary side of the California cannabis industry. The company offers local and international brands key services, such as formulation, manufacturing, co-packing, and distribution for THC & CBD infused products.
- Published in Business, growpacker, Marijuana, Medical Marijuana, News Home